Stockreport

Regeneron launches studies of Kevzara for COVID-19 [Seeking Alpha]

Regeneron Pharmaceuticals, Inc.  (REGN) 
Last regeneron pharmaceuticals, inc. earnings: 2/6 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: investor.regeneron.com
PDF Regeneron Pharmaceuticals (REGN-1.0%Sarilumab is an interleukin-6 (IL-6) receptor antagonist designed to block the action of IL-6, a pro-inflammatory protein (cytokine). [Read more]